INSYS Therapeutics Inc (NASDAQ:INSY)

35.50
Delayed Data
As of Jul 02
 -0.01 / -0.03%
Today’s Change
11.26
Today|||52-Week Range
42.69
+68.41%
Year-to-Date

Today’s Trading

Previous close35.51
Today’s open35.82
Day’s range34.62 - 35.88
Volume553,335
Average volume (3 months)1,017,175
Market cap$2.5B
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-26.06%
Earnings growth (this year)-4.77%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+123.72%
P/E ratio68.2
Price/Sales6.96
Price/Book15.15

Competitors

 Today’s
change
Today’s
% change
CXRXConcordia Healthcare...+1.22+1.69%
MYGNMyriad Genetics Inc+0.23+0.67%
GWPHGW Pharmaceuticals P...-1.32-1.06%
--COSMO Pharmaceutical...+1.20+0.75%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)$0.23
Annual revenue (last year)$222.1M
Annual profit (last year)$38.0M
Net profit margin17.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael L. Babich
Chief Financial &
Accounting Officer
Darryl S. Baker
Corporate headquarters
Chandler, Arizona

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers